OCDX 17.63 (+0.46%)
GB00BMDNH979Medical Diagnostics & ResearchDiagnostics & Research

Ortho Clinical Diagnostics Holdings (OCDX) Competitor Comparison

We are evaluating the key criteria listed to compare Ortho Clinical Diagnostics Holdings (OCDX) against its competitors in the Diagnostics & Research industry.

Linearity 3 years - OCDX ranking 5 / 58

These are the competitors of Ortho Clinical Diagnostics Holdings in the industry Diagnostics & Research ranked by linearity 3 years
1. Anixa Biosciences ANIX
180.99
2. Waters WAT
49.33
3. Sera Prognostics SERA
43.8
4. Laboratory Corp of America Holdings LH
34.56
5. Ortho Clinical Diagnostics Holdings OCDX
33.4
6. PerkinElmer PKI
16.14
7. Quest Diagnostics DGX
10.77
8. Syneos Health SYNH
10.68
9. Agilent Technologies A
9.38
10. Qiagen QGEN
9.28
11. Mettler-Toledo MTD
8.3
12. Twist Bioscience TWST
7.93
13. Heska HSKA
7.67
14. Thermo Fisher Scientific TMO
7.45
15. IDEXX Laboratories IDXX
7
16. Olink Holding OLK
6.67
17. Danaher DHR
6.63
18. NeoGenomics NEO
6.58
19. Exact Sciences EXAS
5.83
20. Icon ICLR
5.57
21. IQVIA Holdings IQV
5.43
22. Global Cord Blood CO
4.22
23. DexCom DXCM
4.06
24. Lantheus Holdings LNTH
4.05
25. Myriad Genetics MYGN
3.62
26. MaxCyte MXCT
3.6
27. Charles River Laboratories CRL
3.57
28. Sotera Health SHC
3.56
29. National Research NRC
3.53
30. Bioventus BVS
3.52
31. Medpace Holdings MEDP
3.46
32. Exagen XGN
3.31
33. Guardant Health GH
3.06
34. Psychemedics PMD
2.83
35. Pacific Biosciences of California PACB
2.73
36. CareDx CDNA
2.67
37. Enzo Biochem ENZ
2.57
38. Fulgent Genetics FLGT
2.5
39. Neogen NEOG
2.48
40. Biodesix BDSX
2.46
41. Personalis PSNL
2.36
42. MDxHealth MDXH
2.36
43. Illumina ILMN
2.17
44. Precipio PRPO
2.12
45. Trinity Biotech TRIB
2
46. Neuronetics STIM
1.98
47. RadNet RDNT
1.82
48. DarioHealth DRIO
1.79
49. Organovo Holdings ONVO
1.79
50. Co-Diagnostics CODX
1.7
51. Interpace Biosciences IDXG
1.68
52. Inotiv NOTV
1.61
53. bioAffinity Technologies BIAF
1.55
54. SeqLL SQL
1.48
55. Prenetics Global PRE
1.39
56. Aspira Womens Health AWH
1.38
57. Natera NTRA
0.73
58. Meridian Bioscience VIVO
0.73

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.